Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MELPHALAN for Amyloidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 145 adverse event reports in the FDA FAERS database where MELPHALAN was used for Amyloidosis.

Most Reported Side Effects for MELPHALAN

Side Effect Reports % Deaths Hosp.
Off label use 2,002 12.5% 437 495
Febrile neutropenia 931 5.8% 145 419
Drug ineffective 853 5.3% 199 213
Neutropenia 810 5.0% 145 246
Mucosal inflammation 804 5.0% 131 254
Plasma cell myeloma 781 4.9% 223 99
Product use in unapproved indication 765 4.8% 144 182
Thrombocytopenia 701 4.4% 118 253
Diarrhoea 698 4.4% 95 343
Pyrexia 667 4.2% 144 346
Pneumonia 650 4.1% 254 382
Disease progression 595 3.7% 155 90
Myelodysplastic syndrome 573 3.6% 231 132
Sepsis 544 3.4% 316 247
Venoocclusive liver disease 464 2.9% 152 130

Other Indications for MELPHALAN

Plasma cell myeloma (4,878) Bone marrow conditioning regimen (2,368) Product used for unknown indication (963) Stem cell transplant (738) Retinoblastoma (715) Diffuse large b-cell lymphoma (595) Neuroblastoma (495) Allogenic stem cell transplantation (374) Hodgkin's disease (351) Autologous haematopoietic stem cell transplant (284)

Other Drugs Used for Amyloidosis

TAFAMIDIS (2,264) LENALIDOMIDE (1,315) BORTEZOMIB (1,044) DEXAMETHASONE (932) TAFAMIDIS MEGLUMINE (641) CYCLOPHOSPHAMIDE (585) POMALIDOMIDE (477) DARATUMUMAB (417) IXAZOMIB (168) PATISIRAN (111)

Related Pages

MELPHALAN Full Profile All Amyloidosis Drugs MELPHALAN Demographics MELPHALAN Timeline